The Department of Justice (DOJ) has taken down what it calls one of the largest healthcare fraud schemes, charging 35 people with unlawfully charging Medicare $2.1 billion.
According to the DOJ, the scheme represents the next big frontier in healthcare fraud: genetic cancer testing.
The DOJ charged nearly three dozen people in five federal districts associated with dozens of telemedicine companies and cancer genetic testing laboratories. According to the charges, these defendants fraudulently billed Medicare more than $2.1 billion for cancer genetic tests. Among those charged are 10 medical professionals, including nine doctors, the DOJ announced in a press release Friday.